Pregabalin in the treatment of depression

	Tweet

Although studies have demonstrated the efficacy of the new anti-epileptic on the block, Pregabalin, in the treatment of Generalized Anxiety Disorder and Social Anxiety Disorder, there is no study so far of such efficacy for the treatment of depression.

This case study in a patient with chronic major depression demonstrates that Pregabalin could be an effective augmenting agent to other anti-depressants, e.g. SSRI’s and SNRI’s. 

This added property of Pregabalin may be related to its probable GABA-ergic mechanism of action that could be soon the emerging treatment pathway for achieving better remission in chronic depression that is yet clinically problematic.

Key Words: Pregabalin • depression • augmentation • anxiety • GABA

Mostafa Showraki
Community Psychiatrists Association of Toronto, Ontario, Canada,

Journal of Psychopharmacology, Vol. 21, No. 8, 883-884 (2007)
DOI: 10.1177/0269881107078496
British Association for Psychopharmacology

Full text

RELATED STORIES:
Compulsive gambling not always a chronic addiction   Researchers Demonstrate First Common Genetic Risk Factors for Autism   The Conflict of Reward in Depression   Combat may raise eating disorder risk in women   Steroids may relieve social and spider phobias   Depression Increases Stroke Risk   Outcomes of Deep Brain Stimulation for Depression Sustained for One Year   Personality Changes May Help Detect Form of Dementia   Switching depression treatment can help   Young females are victims of violent injury   Blood tests may be possible for mental health conditions   Pramipexole in unipolar and bipolar depression   Impulsivity may especially vex alcoholics with antisocial and borderline personality disorders   Music therapy for depression: study   Many facing home foreclosure may have depression

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]